It seems like we learn about a new data breach almost every day. And unfortunately for the pharmaceutical industry, it is an attractive target for fraudulent behavior.
As a professional in the pharmaceutical industry, you likely know that the typical drug costs more than $2.5 billion to develop and takes 10-15 years to bring to market. There is a particular need for pharmaceutical companies to protect drug recipes and research given the richness of their intellectual property (IP). As these organizations rely more and more on technology to conduct business, the industry has become particularly vulnerable to cybercrime. Continue reading "Data Security in Pharmaceuticals: Compliance is Key — But not Enough"
In The Headlines
Brannon Cashion | Addison Whitney
Regulatory approval exists as the final hurdle to product launch – the final sign that this product, which has been studied, tested, researched, strategized – and yes, branded – is ready to find its place on the market. That it’s time for the preparation to pay dividends in making a difference in a patient’s life.
Continue reading "Why Brand Name Development Needs to be a Part of Your Strategic Focus"
Topic of Discussion
Ilyssa Levins | Center for Communication Compliance (CCC)
This article delivers a clarion call to the pharmaceutical industry to recognize, support and champion the medical affairs professional as the cornerstone for reigniting trust in our industry.
- Medical affairs professionals are the face of our industry to healthcare professionals (HCPs) globally; rebuilding and maintaining trust among HCPs is vital
- The primary domains of the medical affairs function – data, quality and safety – are foundations for trust building, according to 2016 data on trust in the pharmaceutical industry
- The three elements for building trust – reliability, competence, sincerity – are integral to/ingrained in how Medical Affairs professionals operate
- HCPs must better understand the role medical affairs professionals play in helping to improve patient outcomes
East Norriton, Penn. Feb. 4, 2016. TGaS® Advisors is expanding its roster of commercial solutions with the addition of Medical Regulatory Legal (MRL) Operations. The new solution reflects high client demand in this critical area. The benchmarking and advisory firm also named TGaS Management Advisor Karl Kraft to head the new practice. The MRL benchmark is in growing demand as companies seek to make this critical process shorter, more efficient, more strategic and less costly, according to ... [Continue Reading]